Panagora Asset Management Inc Travere Therapeutics, Inc. Transaction History
Panagora Asset Management Inc
- $21.7 Billion
- Q2 2025
A detailed history of Panagora Asset Management Inc transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 432,021 shares of TVTX stock, worth $11.9 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
432,021
Previous 335,959
28.59%
Holding current value
$11.9 Million
Previous $6.02 Million
6.2%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding TVTX
# of Institutions
230Shares Held
101MCall Options Held
1.71MPut Options Held
401K-
Janus Henderson Group PLC London, X09.54MShares$262 Million0.07% of portfolio
-
Armistice Capital, LLC New York, NY8.88MShares$244 Million2.3% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$210 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$165 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C35.1MShares$140 Million0.1% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.77B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...